Navigation Links
4th Annual Advancing Global Clinical Trials Conference is Announced
Date:4/16/2013

New York, New York (PRWEB) April 16, 2013

The Conference Forum announced the 4th Annual Global Clinical Trials conference will take place on September 18, 2013 at the Fairmont Copley Plaza in Boston, MA.

Led by industry veteran Dr Christopher Gallen, CEO, of the Korean-based life science company, SK BioPharmaceuticals, the 2013 program places special emphases on how to reduce the complexities of global clinical trials.

Brand new this year is a section on Lessons Learned from Unsuccessful Global Clinical Trials led by Dr. Debra Barker, Chief Scientific Officer, Emerging Markets, Novartis.

"We are really pleased with the outpouring of interest from senior-level executives wanting to be part of the speaking faculty to help the industry with global clinical challenges,” Valerie Bowling, Executive Director of The Conference Forum.

The Global Clinical Trials event received a wonderful response from the industry to be part of the event due to the latest industry developments and advancements as well as the event’s history. The extensive speaking faculty includes Dr. Mitchell Katz, Executive Director, Medical Research Operations, Purdue Pharma; Dr. Marielle Cohard-Radice, Vice President, Clinical Development Operations, Daiichi Sankyo Pharma Development; Jodie Morrison, CEO, Tokai Pharmaceuticals; and Ross Pettit, Vice President, Clinical Operations, AMAG Pharmaceuticals.

Exciting new and hot topics addressed include Re-thinking the Patient Experience; Designing Patient-Centric Protocols to Increase Global Patient Engagement and Reducing Protocol Complexity; and an Update on Risk Based Monitoring.

One of the best-rated and most popular sections of the conference is the regional roundtables, where experts with experience from all over the world (including China, India, Japan, Latin America and the EU) answer one-on-one questions, covering such topics as how to work globally with different regulatory agencies and patient recruitment, enrollment and engagement.

There will be many opportunities for networking, with special breaks, a breakfast and a luncheon. The conference has been described by attendees as having a “congenial and friendly atmosphere with fostered communication between speakers and attendees” as well as being “knowledgeable and interesting, interactive and provocative.”

Full program details are available at http://www.theconferenceforum.org.

Participating Companies

AbbVie, AMAG Pharmaceuticals, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Endo Pharmaceuticals, EnVivo Pharmaceuticals, Genzyme, JANSSEN Alzheimer Immunotherapy, Merck, The Michael J. Fox Foundation for Parkinson’s Research, Millennium: The Takeda Oncology Company, Novartis, Purdue Pharma, SK Bio-Pharmaceuticals, Target Health, Teva Pharmaceuticals, Tokai Pharmaceuticals, United Therapeutics

About The Conference Forum
The Conference Forum develops specialized public and private events and organizes research groups and advisory boards for professionals in the life science industry. The company currently offers conferences for R&D leaders, clinical development professionals, young and established biotech executives, drug delivery professionals and the investment community. Their mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for pharmaceutical and biotech professionals.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10619464.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Infinata's BioPharm Insight Global Editor Kim Ha to Moderate Panel at 3rd Annual U.S.-China Conference on Strategies for Mining Profits from Pharma Opportunities in China
2. New Obesity Education Program To Premiere At American College of Physicians (ACP) Annual Meeting
3. 12,000 Candles: Texas Fertility Center 27th Annual Baby Reunion, Celebrates 12,000 Babies Born
4. NW Bio 2012 Annual Report Shows Strong Progress And Enhancement Of Leadership Position
5. DIA 2013 49th Annual Meeting to Address Hot Topics Surrounding Patient Therapies
6. Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013
7. Susan Cain Will Kick Off 2013 ASAE Annual Meeting & Exposition, Dan Heath is Closing General Session Speaker
8. Electronic Headband That Detects and Treats Addictive In-Sleep Behavior to be Demonstrated at Annual Holistic Dental Conference by Holistic Technologies
9. Professional Pricing Society Explores New Role of Pricers as Change Agents and Leaders at 24th Annual Spring Conference
10. Upsher-Smith Presents Favorable Phase I Data For USL261, A Novel Formulation Of Intranasal Midazolam, At 65th Annual Meeting Of The American Academy Of Neurology
11. NW Bio To Review Its Leadership Position In Immune Therapy At The 25th Annual Roth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... 2016 A person commits a crime, and the ... track the criminal down. An outbreak of foodborne ... Administration (FDA) uses DNA evidence to track down the bacteria ... far-fetched? It,s not. The FDA has increasingly used a complex, ... foodborne illnesses. Put as simply as possible, whole genome sequencing ...
(Date:6/23/2016)... 2016   EpiBiome , a precision microbiome engineering ... debt financing from Silicon Valley Bank (SVB). The financing ... advance its drug development efforts, as well as purchase ... "SVB has been an incredible strategic partner to us ... bank would provide," said Dr. Aeron Tynes Hammack ...
Breaking Biology Technology:
(Date:5/9/2016)... , UAE, May 9, 2016 ... when it comes to expanding freedom for high net ... Even in today,s globally connected world, there is ... conferencing system could ever duplicate sealing your deal with ... obtaining second passports by taking advantage of citizenship via ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
Breaking Biology News(10 mins):